anti-Interferon Induced Transmembrane Protein 5 (IFITM5) Anticorps

Plays a role in bone mineralization (By similarity).. De plus, nous expédions IFITM5 Protéines (3) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
IFITM5 293617  
IFITM5 387733 A6NNB3
IFITM5 73835 O88728
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-IFITM5 Anticorps sur anticorps-enligne.fr

Showing 10 out of 38 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-IFITM5 Antibody Titration:  0.2-1 ug/ml  Positive Control:  Hela cell lysate WB Suggested Anti-IFITM5  Antibody Titration: 0.2-1 µg/mL  Positive Control: Hela cell lysate 100 μL 2 to 3 Days
$289.00
Détails
Humain Lapin Inconjugué EIA, WB IFITM5 Antibody (Center) western blot analysis in mouse spleen tissue lysates (35µg/lane).This demonstrates the IFITM5 antibody detected the IFITM5 protein (arrow). 0.4 mL 6 to 8 Days
$484.00
Détails
Cobaye Lapin Inconjugué WB 100 μL 11 to 14 Days
$551.83
Détails
Humain Lapin Inconjugué WB Western blot analysis in mouse spleen tissue lysates (35ug/lane). 400 μL 2 to 3 Days
$515.63
Détails
Humain Lapin Inconjugué IHC (p) Immunohistochemical staining of human duodenum with IFITM5 polyclonal antibody  shows distinct membranous positivity in glandular cells at 1:50-1:200 dilution. 100 μL 11 to 12 Days
$577.33
Détails
Humain Lapin Inconjugué ELISA, WB   200 μL 11 to 16 Days
$658.43
Détails
Humain Lapin Alkaline Phosphatase (AP) ELISA, WB   200 μL 11 to 14 Days
$1,101.83
Détails
Humain Lapin APC ELISA, WB   200 μL 11 to 14 Days
$1,101.83
Détails
Humain Lapin FITC ELISA, WB   200 μL 11 to 14 Days
$1,101.83
Détails
Humain Lapin PE ELISA, WB   200 μL 11 to 14 Days
$1,101.83
Détails

Plus d’anticorps contre IFITM5 partenaires d’interaction

Human Interferon Induced Transmembrane Protein 5 (IFITM5) interaction partners

  1. Two mutations in IFITM5 causing distinct forms of osteogenesis imperfect.

  2. The point mutation, c.-14C>T in the 5'-untranslated region of IFITM5, is responsible for osteogenesis imperfecta type V in Chinese patients.

  3. The IFITM5 5' UTR was sequenced in 9 heterozygous subjects with osteogenesis imperfecta type V. Both wild-type and mutant IFITM5 mRNA transcripts were present in bone. Identical mutations have variable phenotypic expression, even within the same family.

  4. The bone mineral density varied greatly, even within families. Our study thus highlights the phenotypic variability of OI type V caused by the IFITM5 mutation.

  5. Recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.

  6. IFITM5 mutation is associated with Osteogenesis imperfecta type V.

  7. study demonstrates the presence of a recurrent IFITM5 mutation in a population of patients with osteogenesis imperfecta type V; even though the disease-causing mutation is identical among patients, the interindividual phenotypic variability is considerable

  8. A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.

  9. A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.

Mouse (Murine) Interferon Induced Transmembrane Protein 5 (IFITM5) interaction partners

  1. IFITM5 was expressed in the dental follicle and the developing alveolar bone

  2. results suggest that expression of mutant IFITM5 causes abnormal skeletal development, low bone mass, and abnormal osteoblast differentiation

  3. The purpose of the current study was to re-assess the topology, localization, and biochemical properties of BRIL and compare it to the osteogenesis imperfecta type V mutant in MC3T3 osteoblasts.

  4. These results indicate that the S-palmitoylation on IFITM5 promotes the interaction with FKBP11.

  5. Key roles for the Sp members and GLI2 that possibly cooperate to activate Bril when the promoter becomes demethylated.

  6. Natural antisense transcripts enhance bone formation by increasing sense IFITM5 transcription.

  7. Ifitm5 deficiency might have a greater effect on prenatal bone development.

  8. these results suggest that IFITM5 is involved not only in bone formation, but also in immune system activity.

  9. Bril is a novel osteoblast protein and showed a role in mineralization, possibly identifying a new regulatory pathway in bone formation.

IFITM5 profil antigène

Profil protéine

Plays a role in bone mineralization (By similarity).

Gene names and symbols associated with IFITM5

  • interferon induced transmembrane protein 5 (Ifitm5) anticorps
  • interferon induced transmembrane protein 5 (IFITM5) anticorps
  • interferon-induced transmembrane protein 1 (LOC606890) anticorps
  • 1110003J06Rik anticorps
  • AW213665 anticorps
  • Bril anticorps
  • DSPA1 anticorps
  • fragilis4 anticorps
  • Hrmp1 anticorps
  • Hrtm1 anticorps
  • OI5 anticorps

Protein level used designations for IFITM5

interferon-induced transmembrane protein 5 , interferon induced transmembrane protein 5 , bone-restricted ifitm-like protein , bone-restricted interferon-induced transmembrane protein-like protein , dispanin subfamily A member 1 , bone-restricted interferon induced transmembrane protein-like protein , fragilis family member 4 , fragilis4 , haemopoiesis related membrane protein 1

GENE ID SPECIES
293617 Rattus norvegicus
422992 Gallus gallus
450915 Pan troglodytes
526461 Bos taurus
606890 Canis lupus familiaris
697314 Macaca mulatta
387733 Homo sapiens
73835 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-IFITM5 (IFITM5) Anticorps
Avez-vous cherché autre chose?